Tenofovir clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR

    open to eligible males ages 18 years and up

    This is a Phase 2, multi-site, two-period, open label randomized crossover (Period 1 and 2) study. Participants are randomized 1:1 to one of two 8-week on-demand product sequences - TFV douche then oral F/TDF or oral F/TDF then TFV douche - with a 2 to 4-week washout period in between. Domains of safety, acceptability, adherence, and PK/PD (sub-study only) are assessed for each product.

    Los Angeles, California and other locations

Our lead scientists for Tenofovir research studies include .

Last updated: